Cargando…

Comparison of the Fatty Acid Metabolism Pathway in Pan-Renal Cell Carcinoma: Evidence from Bioinformatics

This study analyzed and compared the potential role of fatty acid metabolism pathways in three subtypes of renal cell carcinoma. Biological pathways that were abnormally up- and downregulated were identified through gene set variation analysis in the subtypes. Abnormal downregulation of the fatty ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ping, Xu, Yingkun, Li, Jiayi, Li, Xiaowei, Zhang, Peizhi, Ruan, Ningke, Zhang, Cong, Sun, Panpan, Wang, Qifei, Wu, Guangzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925032/ https://www.ncbi.nlm.nih.gov/pubmed/33688464 http://dx.doi.org/10.1155/2021/8842105

Ejemplares similares

Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Qi, Xiaochen, et al.
Publicado: (2021)

Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma
por: Li, Jianyi, et al.
Publicado: (2020)

Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target
por: Wu, Guangzhen, et al.
Publicado: (2021)

Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types
por: Wu, Guangzhen, et al.
Publicado: (2020)

The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma
por: Wang, Qifei, et al.
Publicado: (2023)

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
por: Xu, Yingkun, et al.
Publicado: (2020)

Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration
por: Wu, Guangzhen, et al.
Publicado: (2020)

The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients
por: Wang, Zicheng, et al.
Publicado: (2022)

Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
por: Zhang, Peizhi, et al.
Publicado: (2023)

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway
por: Che, Xiangyu, et al.
Publicado: (2022)

Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
por: Xu, Yingkun, et al.
Publicado: (2020)

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
por: Xu, Yingkun, et al.
Publicado: (2020)

Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma
por: Li, Xiunan, et al.
Publicado: (2022)

A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data
por: Xu, Yingkun, et al.
Publicado: (2020)

Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction
por: Che, Xiangyu, et al.
Publicado: (2021)

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
por: Qi, Xiaochen, et al.
Publicado: (2021)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
por: Wang, Jin, et al.
Publicado: (2022)

Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Yonghao, et al.
Publicado: (2022)

Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019)

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway
por: Zhang, Peizhi, et al.
Publicado: (2022)

Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer
por: Ping, Wei, et al.
Publicado: (2022)

Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis
por: Wu, Ping, et al.
Publicado: (2021)

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N(6)-Methyladenosine RNA Methylation Regulators
por: Zhang, Yan, et al.
Publicado: (2021)

Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma
por: GE, WENFEI, et al.
Publicado: (2023)

Potential value of mitochondrial regulatory pathways in the clinical application of clear cell renal cell carcinoma: a machine learning-based study
por: Qi, Xiaochen, et al.
Publicado: (2023)

Research progress in inducing immunogenic cell death of tumor cells
por: Xie, Deqian, et al.
Publicado: (2022)

LAPTM5 Plays a Key Role in the Diagnosis and Prognosis of Testicular Germ Cell Tumors
por: Li, Xiunan, et al.
Publicado: (2021)

Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

PanACEA: a bioinformatics tool for the exploration and visualization of bacterial pan-chromosomes
por: Clarke, Thomas H., et al.
Publicado: (2018)

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
por: Xie, Deqian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_315e6fd179j38jq8q7dj0uo1em